RALYL and central nervous system cancer: We compared the expression levels of FAIM2, DLGAP2, ATP1B1 and RALYL using ONCOMINE databases and found that these 4 genes were significantly downregulated in brain and CNS cancer compared with the normal group (Figure 7A).